Projects and Grants per year
Personal profile
Research Interests
Lung cancer, signaling, autophagy.
Education/Academic qualification
Doctor of Philosophy, University Of North Carolina
1996
Master of Science, University Of Illinois- Chicago
1987
Bachelor of Science, Clemson University
1985
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Rolf Craven is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Projects & Grants
- 16 Finished
-
A targetable mechanism in insulin-resistant diabetes
Craven, R. (PI)
Washington University in St. Louis
2/23/13 → 11/30/16
Project: Research project
-
Craven S2RPGRMC1: Sigma-2 receptor as a therapeutic target in lung cancer
Craven, R. (PI)
Bonnie J Addario Lung Cancer Foundation
1/1/12 → 6/30/15
Project: Research project
-
Stable Isotope-Derived Metabolomics to Elucidate the Mechanism of a Tumor-Associated Cytochrome in Lung Cancer Growth and Metabolism
Craven, R. (PI)
12/1/10 → 5/31/13
Project: Research project
-
KSEF RDE: Novel Small Molecule Inhibitors Targeting Cancer Growth via EGFR
Craven, R. (PI)
KY Science and Technology Co Inc
7/1/10 → 6/30/11
Project: Research project
-
KSEF RDE: Novel Small Molecule Inhibitors Targeting Cancer Growth via EGFR
Craven, R. (PI)
KY Science and Technology Co Inc
7/1/10 → 6/30/12
Project: Research project
-
Focal Adhesion Kinase Intersects With the BRD4-MYC Axis and YAP1 to Drive Tumor Cell Growth, Phenotypic Plasticity, Stemness, and Metastatic Potential in Colorectal Cancer
Han, R., Shi, J., Cheng, K., Wang, Z., Chen, Y., Spellecy, O., Faisal, A. S. M., Aryal, I., Chen, J., Craven, R., Thibault, O., Baldwin, L., Brewer, L. D., Erfani, S., Wang, C., Guo, Z., Chen, E., Yang, B., Ueland, F. & Guo, R. & 1 others, , Sep 2025, In: Cancer Medicine. 14, 18, e71227.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies
Wei, Y., Erfani, S., Schweer, D., de Gouvea, R., Qadir, J., Shi, J., Cheng, K., Wu, D., Craven, R., Wu, Y., Olivier, T., Baldwin, L. A., Zhou, B., Zhou, Y., Zhao, W., Yang, B. B., Ueland, F. R. & Yang, X. H., Mar 16 2023, In: Molecular Therapy Oncolytics. 28, p. 293-306 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
Dependence of glucose transport on autophagy and GAPDH activity
Craven, R. J., Frazier, H. N. & Thibault, O., Feb 1 2022, In: Brain Research. 1776, 147747.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
GAPDH in neuroblastoma: Functions in metabolism and survival
Cornett, K., Puderbaugh, A., Back, O. & Craven, R., Oct 4 2022, In: Frontiers in Oncology. 12, 979683.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways
Zhang, Y., Xu, B., Shi, J., Li, J., Lu, X., Xu, L., Yang, H., Hamad, N., Wang, C., Napier, D., He, S., Liu, C., Liu, Z., Qian, H., Chen, L., Wei, X., Zheng, X., Huang, J. A., Thibault, O. & Craven, R. & 5 others, , Dec 2020, In: Cellular Oncology. 43, 6, p. 1049-1066 18 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations